1. Home
  2. ONCY vs STHO Comparison

ONCY vs STHO Comparison

Compare ONCY & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.89

Market Cap

109.1M

Sector

Health Care

ML Signal

HOLD

STHO

Star Holdings Shares of Beneficial Interest

HOLD

Current Price

$9.83

Market Cap

118.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
STHO
Founded
1998
2022
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
109.1M
118.3M
IPO Year
2002
2022

Fundamental Metrics

Financial Performance
Metric
ONCY
STHO
Price
$0.89
$9.83
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
596.3K
17.1K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.73
EPS
N/A
2.58
Revenue
N/A
$110,143,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,505.00
N/A
P/E Ratio
N/A
$3.73
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$7.08
52 Week High
$1.51
$9.94

Technical Indicators

Market Signals
Indicator
ONCY
STHO
Relative Strength Index (RSI) 57.13 51.81
Support Level $0.85 $8.71
Resistance Level $1.08 $9.76
Average True Range (ATR) 0.04 0.28
MACD 0.00 -0.02
Stochastic Oscillator 100.00 66.31

Price Performance

Historical Comparison
ONCY
STHO

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties, and land and development properties.

Share on Social Networks: